Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Coronary Artery Disease|October 24, 2002
Variation in the lipoprotein receptor-related protein, alpha2-macroglobulin and lipoprotein receptor-associated protein genes in relation to plasma lipid levels and risk of early myocardial infarctionPelayo González, Ruth Alvarez, Julián R Reguero, et al.
Mbio|April 18, 2019
Identification of the Bacterial Biosynthetic Gene Clusters of the Oral Microbiome Illuminates the Unexplored Social Language of Bacteria during Health and DiseaseGajender Aleti, Jonathon L Baker, Xiaoyu Tang, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 17, 2026
SEOM-TTCC clinical guideline for nasopharyngeal carcinoma (update 2025)Antonio Rueda Domínguez, Beatriz Cirauqui, Almudena García Castaño, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 18, 2022
SEOM-TTCC clinical guideline in nasopharynx cancer (2021)Antonio Rueda Domínguez, Beatriz Cirauqui, Almudena García Castaño, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|April 22, 2014
Differences in cerebrospinal fluid inflammatory cell reaction of patients with leptomeningeal involvement by lymphoma and carcinomaJulia Illán, Marta Simo, Cristina Serrano, et al.
Leukemia & Lymphoma|April 12, 2013
Consolidation treatment with Yttrium-90 ibritumomab tiuxetan after new induction regimen in patients with intermediate- and high-risk follicular lymphoma according to the follicular lymphoma international prognostic index: a multicenter, prospective phase II trial of the Spanish Lymphoma Oncology GroupMariano Provencio, Miguel Á Cruz Mora, José Gómez-Codina, et al.
Lung Cancer (Amsterdam, Netherlands)|October 1, 2025
Durvalumab plus platinum-etoposide in the first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): A single-arm clinical trialDolores Isla, Jon Zugazagoitia, Edurne Arriola, et al.
Cancers|November 27, 2025
Real-World Data of First-Line Cemiplimab Monotherapy for Metastatic Non-Small Cell Lung Cancer (NSCLC) with PD-L1 Expression ≥ 50%: A National Spanish Multicentric Cohort (CEMI-SPA Study)Silvia Masini, Monica Antoñanzas Basa, Antonio Calles, et al.
Pageof 2